Clinical trials
Phase 2 Fibromyalgia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 5 |
| 2005 | 7 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 7 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Terminated | 7 |
| Unknown status | 7 |
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aptinyx | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
| Federal University of São Paulo | 2 |
| Forest Laboratories | 2 |
| Rambam Health Care Campus | 2 |
| UCB Pharma | 2 |
| University of Utah | 2 |
| University of Washington | 2 |
| Ain Shams University | 1 |
| Ajay Wasan, MD, Msc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibromyalgia | 80 |
| Pain | 16 |
| Chronic Pain | 14 |
| Fatigue | 5 |
| Fatigue Syndrome, Chronic | 3 |
| Anxiety Disorders | 2 |
| Back Pain | 2 |
| Irritable Bowel Syndrome | 2 |
| Marijuana Abuse | 2 |
| Migraine Disorders | 2 |
Trials
Showing 76 to 80 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.